El-Ghafar, Omnia Ahmed Mohamed Abd <br/><br/>
Apixaban exhibits anti-arthritic effects by inhibiting activated factor X-mediated JAK2/STAT3 and MAPK phosphorylation pathways.  [electronic resource] 

 -  Inflammopharmacology  Oct 2020 
 - 1253-1267 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1568-5608 
<br/><br/><label>Standard No.: </label>10.1007/s10787-020-00693-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--pharmacology<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Experimental--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Disease Progression<br/>Factor Xa--drug effects<br/>Factor Xa Inhibitors--pharmacology<br/>Female<br/>Janus Kinase 2--metabolism<br/>MAP Kinase Signaling System--drug effects<br/>Phosphorylation--drug effects<br/>Pyrazoles--pharmacology<br/>Pyridones--pharmacology<br/>Rats<br/>Rats, Wistar<br/>STAT3 Transcription Factor--metabolism